API

  • Placeholder
  • Placeholder
  • Placeholder
    API

    Lacosamide

    CAS: 175481-36-4
    Status:Validated
    Certificate:CEP, COPP, WC

  • lanreotide
    API

    Lanreotide

    CAS:108736-35-2
    Status:DMF (2025)
    Indications:Tumors, as well as endocrine, nutritional, and metabolic diseases
  • Placeholder
    API

    Lanthanum Carbonate

    CAS: 54451-24-0
    Status:Validated

  • Placeholder
    API

    Lenvatinib mesylate

    CAS:857890-39-2

  • auto draft
    API

    Leuprorelin

    CAS:53714-56-0
    Status:CEP
    Indications:Tumors and diseases of the urogenital system
  • Placeholder
    API

    Levobupivacaine HCl

    CAS: 27262-48-2
    Status:Validated

  • Placeholder
    API

    Levosimendan

    CAS: 141505-33-1
    Status:Validated
    Certificate:WC

  • linaclotide
    API

    Linaclotide

    CAS:851199-59-2
    Status:DMF, NMPA, WC
    Indications:Diseases of the digestive system
  • Placeholder
    API

    Linzagolix choline

    CAS: 1321816-57-2
    Status:Pilot

     

     

  • auto draft
    API

    Liraglutide

    CAS:204656-20-2
    Status:DMF, TGA, NMPA, WC
    Indications:Endocrine, nutritional, and metabolic diseases

Scroll to Top